Although aging is considered to be an unavoidable event, recent experimental evidence suggests that the process can be delayed, counteracted, if not completely interrupted. Aging is the primary risk factor for the onset and development of neurodegenerative conditions like Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis. Intracellular calcium (Ca 2+ i) dyshomeostasis, mitochondrial dysfunction, oxidative stress, and lipid dysregulation are critical factors that contribute to senescence-related processes. Ceramides, a class of sphingolipids involved in a wide array of biological functions, are important mediators of cellular senescence, but their role in neuronal aging is still largely unexplored.
Introduction
Aging is the time-dependent process characterized by the loss of the physiological integrity of living organisms 1 . Although this process has been long considered to be unavoidable, recent evidence has shown that it can be delayed, if not altogether interrupted 2 . Many factors, including environmental exposure and molecular changes, contribute to the senescence-related processes 1, 3 . The molecular effectors promote several cellular modifications like DNA damage, the activation of cell death pathways, the loss of proteostasis, cation dyshomeostasis, mitochondria dysfunction, and lipid dysregulation 1, [4] [5] [6] . Ceramides are a class of sphingolipids involved in a wide array of biological functions including cell growth, proliferation, differentiation, and programmed cell death as well as cellular senescence 7 . The application to cell cultures of exogenous ceramides induces, in a dose-dependent and reversible manner, the expression of senescence markers 8 . In parallel, cellular senescence is associated with the increase of ceramide levels, a phenomenon found in age-related neurological conditions like Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS) patients as well as in brain aging [9] [10] [11] [12] [13] . Ceramides originate from one of two main enzyme-mediated processes: de novo biosynthesis from palmitoyl-CoA and serine, or cleavage of sphingolipid precursors in membranes 14 .
The former pathway involves three sequential reactions in which the enzyme serine palmitoyl transferase (SPT) serves as rate-limiting step 14 . Importantly, pharmacological blockade of SPT activity has shown promising anti-aging and neuroprotective effects in in vitro and in vivo models of cellular senescence 15, 16 . To gain further insights on the role played by ceramides in neuronal aging, we used Lcycloserine (L-CS), an amino acid that inhibits SPT activity both safely and selectively, and has been employed both in vitro and in vivo settings to reduce de novo ceramide biosynthesis 15, [17] [18] [19] [20] . We evaluated age-driven changes occurring in young and aging neuronal cultures exposed to vehicle or L-CS, focusing on alterations in cytosolic and subcellular calcium [Ca 2+ ]i handling, mitochondrial functioning, spontaneous neuronal Ca 2+ signaling, and activation of age-related and ceramide-driven molecular pathways.
Results
To examine the effects of L-CS on neuronal aging, experiments were performed in long-term culture of primary cortical neurons (hereafter termed 'aged' neurons ) used here as an in vitro model of neuronal senescence [21] [22] [23] . Cultures were maintained for 18-19 days in vitro (DIV) and then treated with L-CS (30 µM) or vehicle (serum-free medium) for an additional three days. At the end of treatment (at 21-22 DIV), cultures were analyzed for morphological and functional changes or harvested for further biochemical analyses (Fig. 1A) . Data collected from aged neurons were compared with those obtained from vehicle-or drug-treated cultures at 11-12 DIV and assayed at 14-15 DIV (hereafter termed 'control' neurons). Routinely performed visual inspections of the cultures showed that aged neurons did not display overt signs of death or injury (Fig. 1B) , thereby supporting the notion that the functional and biochemical changes that we have observed occurred upstream of mechanisms leading to neuronal death.
L-CS reduces de novo ceramide biosynthesis in aged cultured neurons
To test the drug-driven effects on ceramide biosynthesis, we quantified sphingolipids and ceramides by Liquid Chromatography/Mass Spectrometry (LC/MS-MS) in lipid extracts obtained from control and aged cultures that underwent vehicle-or L-CS-treatment (Fig. 1A, B) . Analysis of the lipid profiles indicates that aged neurons respond to the 3-day L-CS treatment with a significant reduction in the levels of total ceramides (d18:1/16:0, d18:1/18:0, d18:1/22:0, and d18:1/24:0; Fig.  1C ) and sphinganine ( Supplementary Fig. 1 ). Aged cultures also showed a trend toward a statistically significant increase in ceramide levels when compared to control neurons ( Supplementary Fig. 1 ). Of note, the ceramide reduction appears to be mainly driven by inhibition of the de novo pathway as sphinganine (an intermediate of the de novo pathway), but not sphingosine (which can generate ceramide through sphingomyelin hydrolysis), was found to be affected by the L-CS treatment ( Supplementary Fig. 1 ).
L-CS reduces resting Ca
2+ levels in aged neurons The effects of 3-day L-CS or vehicle treatment on [Ca 2+ ]i were measured by using the highaffinity (Kd≈140nM) ratiometric dye fura-2. The analysis of resting fura-2 signals showed that no regional differences in [Ca 2+ ]i levels were detectable in proximal or distal dendrites of aged or control neurons treated with either vehicle or L-CS ( Fig. 1D-F) . By contrast, L-CS treatment caused a reduction in resting somatic [Ca 2+ ]i levels in aged neurons (Fig. 1G) . Of note, a ≈40% increase in resting [Ca 2+ ]i was observed when comparing vehicle-treated control and aged neurons, thereby lending support to the notion that our in vitro senescence model exhibits signs of age-dependent Ca 2+ dyshomeostasis 5, 24 . No significant differences were observed when comparing vehicle-and drug-treated control neurons (Fig. 1G ).
L-CS treatment marginally affects main neuronal Ca
2+ stores Mitochondria and the endoplasmic reticulum (ER) constitute the main intracellular Ca 2+ stores. To test whether Ca 2+ accumulation in these organelles is affected by L-CS treatment, fura-2-loaded control and aged neurons were exposed to 5 µM carbonyl cyanide 3-chlorophenylhydrazone (CCCP, a mitochondrial uncoupler that collapses the mitochondrial membrane potential, Δp) or 10 µM cyclopiazonic acid [CPA, a sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) inhibitor], two agent employed to promote cation release from mitochondria or the ER, respectively. Analysis of the cytosolic [Ca 2+ ]i changes showed that exposure to L-CS did not affect mitochondrial Ca 2+ release ( Fig. 2A-C) . A significant increase in mitochondrial Ca 2+ release was instead found in aged neurons ( Fig. 2A-C) . As our cultures showed modest and inconsistent CPA-dependent ER-Ca 2+ release (data not shown) and to facilitate the evaluation of this pathway, ER was pre-loaded with Ca 2+ derived from the opening of the voltage-gated Ca 2+ channels (VGCCs) as result of a 5-min depolarization induced by exposing cultures to 60 mM K + . Compared to vehicle-treated and age-matched neurons, Ca 2+ released from the ER was found to be lower in L-CS-treated control cultures ( Fig. 2D-F ). No differences were observed when comparing vehicle-treated control neurons with vehicle-and L-CStreated aged cultures (Fig. 2D-F ).
L-CS treatment does not modify NCX activity
Ceramides can modulate the activity of the plasmalemmal Na + -Ca 2+ exchanger (NCX) 25 , a low capacitance high-affinity system that critically regulates cellular [Ca 2+ ]i. We, therefore, investigated the effects of ceramide on NCX functioning in L-CS or vehicle-treated cultures. Data obtained from this set of experiments were compared with the ones originated from age-matched and vehicletreated sister cultures. In the experiments, fura-2 loaded neurons were exposed to a Ca 2+ free medium while in the presence of the Na + /K + -ATPase pump blocker, ouabain (100 µM), a maneuver set to promote the intracellular accumulation of Na + . Ouabain-treated cultures were then switched to a Na + -free medium to force the NCX to operate in the reverse mode to promote Ca 2+ influx. Analysis of the cytosolic [Ca 2+ ]i rises showed that L-CS does not affect NCX activity in control and aged cultures treated with either vehicle-or L-CS (Fig. 2G-H) . Changes in NCX functioning were observed; however, when comparing [Ca 2+ ]i rises in control and aged cultures ( Fig. 2G-H ).
L-CS treatment reduces age-driven mitochondrial dysfunction
Mitochondrial functioning is a key target of the aging process 2, 21 . In our experimental setting, effects on the organelle membrane potential were assessed by employing tetramethyl rhodamine ethyl ester (TMRE), a mitochondrial probe sensitive to changes of Δp. TMRE-loaded neurons were imaged for up to 60 seconds under resting conditions and after exposure to 10 µM CCCP, a maneuver that promotes a rapid and complete loss of Δp. Data from this set of experiments indicate that aging neurons display signs of mitochondria dysfunction when compared to control cultures. L-CS treatment was effective in reducing the Δp loss in aging neurons (Fig. 3A-C) . A modest (≈10%) increase was also observed in L-CS-treated control neurons when compared with agematched cultures (Fig. 3A-C) . In a subset of experiments, we also evaluated age-dependent changes in mitochondrial morphology of the cultured neurons. To that aim, neurons loaded with Mitotracker, a Δp -independent mitochondrial stain, were imaged with super-resolution confocal microscopy and analyzed with the Mitochondrial Network Analysis (MiNA) toolkit 26 . Surprisingly, no significant age-dependent morphological changes were found ( Fig. 3D and Supplementary Table 1) .
L-CS treatment reduces reactive oxygen species (ROS) generation in aged cultures
Aberrant ROS generation and accumulation of ROS-driven by-products are key features of aging 27 . To assess the effect of L-CS treatment on ROS production, we employed the probe hydroethidine (HEt). Cortical cultures were loaded with HEt and basal fluorescence signals recorded. The results show that aged neurons exhibit increased ROS production, compared to controls (Fig.  3E ). L-CS administration abrogated the effects of age (Fig. 3E ).
L-CS treatment reduces age-driven neuronal hyperexcitability in vitro
To assess whether L-CS treatment affects spontaneous [Ca 2+ ]i transients, an index of neurodegenerative hyperexcitability, we employed high-speed real-time microfluorimetric Ca 2+ imaging 28 . Cultures were loaded with the single wavelength, high-affinity (Kd ≈ 335 nM) and Ca 2+ sensitive fluorescent probe fluo-4 and spontaneous changes in somatic [Ca 2+ ]i were evaluated in terms of spike frequency and amplitude. In line with previous studies 29 , aged neurons showed an increased number of transients per minute, coupled with decreased Ca 2+ spike amplitude, when compared with control cells (Fig. 4A-D) . Compared with age-matched sister cultures, L-CS treatment resulted in a significant reduction of spike frequency and increased transient amplitudes in both control and aged cultures (Fig. 4A-D 4C ). Similar differences in somatic Ca 2+ i transients were obtained when replicating the experiments with the slower (but ratiometric) dye fura-2 (data not shown). Overall, these findings indicate that L-CS treatment reduces the altered somatic Ca 2+ signaling driven by spontaneous synaptic activity.
L-CS treatment reduces the age-related markers of neuronal demise
To test whether L-CS affects the molecular markers that modulate neuronal functioning, western blot (WB) analyses were performed on cell lysates from vehicle-and drug-treated cultures. When compared to control cultures, WB analysis of aged neurons showed increased expression levels of p53 and increased phosphorylation, and thus activation, of JNK, two molecules implicated in the regulation of cellular senescence programs ( Fig. 5A -B) 30, 31 . These age-driven changes were reverted by L-CS treatment ( Fig. 5A-B ). The drug also promoted a reduction of pP38 levels, a kinase associated with senescence ( Fig. 5C ). When analyzed by ANOVA, the changes showed a trend towards significance ( Fig. 5C ; Tukey post-hoc test, P=0.06) and reached statistical significance when not corrected for multiple comparisons (Fisher LSD post-hoc test, P=0.01). No drug-related effects were observed in the control cultures (Fig. 5C ). In parallel, we investigated age-and drug-related effects on the active forms of AKT and ERK5 (pAKT and pERK5, respectively), two kinases involved in neuronal survival 32, 33 . L-CS treatment was effective in reverting age-driven down-regulation of pERK5 and pAKT ( Fig. 5D-E) . The drug also promoted increased pAKT levels in control cultures (Fig.  5D ). Overall, these findings indicate that L-CS treatment decreases the levels of senescenceassociated markers and, at the same time, corrects age-driven loss of pro-survival molecules.
Discussion
In this study, we used an in vitro model to characterize the effects of pharmacological blockade of de novo ceramide biosynthesis on neuronal senescence. The results indicate that exposure to the SPT inhibitor, L-CS, concurrently lowers ceramide levels in aged neurons and attenuates critical molecular and functional changes induced by aging. In particular, we found that L-CS actively counteracts the age-related mitochondrial dysfunction and neuronal Ca 2+ dyshomeostasis.
Age-related functional and molecular changes on cultured cortical neurons
Long-term culturing of cortical neurons promoted significant changes in cytosolic and subcellular [Ca 2+ ]i levels (Figs. 1 and 2). These findings are in line with and lend further support to the "Ca 2+ hypothesis of brain aging" 24, 34, 35 . This model posits that changes in the mechanisms that regulate [Ca 2+ ]i homeostasis play a pivotal role in the expression of physiological and pathological aging 35 . Our findings extend this notion and indicate that age-driven [Ca 2+ ]i dysregulation extend to and differentially affects subcellular compartments.
A large body of evidence indicates that mitochondrial dysfunction is a crucial regulator of cellular senescence and age-related pathologies 1, 36, 37 . In agreement with this notion, our aged neurons show overt signs of mitochondrial Ca 2+ accumulation and organelle dysfunction, as indicated by the presence of significant Δp loss when compared to control cultures (Fig. 3) . Unexpectedly, no significant changes in mitochondrial morphology, a proxy of the organelle and cellular health, were found in the aged neurons (Fig. 3D) . A possible explanation for this lack of effect might be found in work indicating that functional alterations often precede the appearance of morphological changes 38 . Mitochondria are also the primary generator of ROS ( Supplementary Fig.  2 ) and compelling evidence indicates that the organelle dysfunction participates in the build-up of oxidative stress that occurs upon aging 1 . In line with this notion, we found that aged neurons show a modest (≈20%) but significant increase in ROS production when compared to control neurons at rest (Fig. 3E) .
No changes were observed in the amount of ER-Ca 2+ release when comparing aging and control neurons (Fig. 2D-E) , thereby ruling out a significant contribution exerted by ER stress on the senescent phenotype of our cells. Similarly, when comparing aged and control cultures, no significant changes were observed in the overall activity of the NCX (Fig. 2F-H) . However, age-driven alterations in the NCX timing of activation were observed (Fig. 2F ), a modification that may contribute to the [Ca 2+ ]i alterations observed in our model 39 . Growing evidence indicates that neuronal hyperexcitability is a crucial early feature of agingrelated conditions, such as AD 28, 40, 41 . Previous findings from our and other laboratories have shown that neuronal cultures display patterns of spontaneous Ca 2+ oscillations that mirror the neuronal firing status and the in vivo phenotype 28, 40, 41 . The analysis of this spontaneous synaptic activity indicates that aged neurons exhibit an increased frequency of [Ca 2+ ]i transients along with decreased spike amplitudes, two indirect signs of hyperexcitability 28, 41 . These findings parallel in vivo observations in hippocampal and cortical neurons of clinical and preclinical models of physiopathological aging 29, [42] [43] [44] . Along with functional changes, aged cortical neurons showed alterations in molecular hallmarks associated with neuronal senescence [45] [46] [47] . We found that aged neurons exhibit higher expression levels of p53 and increased activation of pJNK and pP38, three molecules implicated in neuronal demise 48, 49 . In parallel, we observed an age-dependent decrease in the levels of the prosurvival kinases pAKT and pERK5 32, 50 .
Functional and molecular effects of L-CS on aged neurons
L-CS supplementation is largely employed in in vitro and in vivo settings to promote a robust decrease in ceramide levels through the inhibition of the de novo biosynthetic pathway 15, 19, 20, [51] [52] [53] [54] . In line with this notion, L-CS was effective in reducing the ceramide pool in our aged neurons when compared to vehicle-treated cells. A modest drug-related effect was also observed in control cells. This discrepancy can be explained by previous findings indicating that the de novo pathway plays a primary role in ceramide biosynthesis during senescence 15 , a mechanism likely occluded in our control cultures. Ceramide accumulation, following acute stressful challenges, participates in the activation of apoptosis in several cellular systems, including neurons. Given the central role of mitochondria in the activation of apoptotic signals, it is therefore conceivable that the L-CS-driven reduction in ceramide levels may also affect the organelle functioning. In line with this notion, we found a robust recovery (≈50%) of the mitochondrial Δp and a reduction of the ROS production in L-CS-treated neurons when compared to vehicle-treated aged-matched cultures. These findings are also in line with previous reports showing that ceramides contribute to mitochondrial dysfunction by impairing the organelle electron transport chain, generating ROS, and promoting the permeabilization of the mitochondrial outer membrane 55, 56 . ROS also contribute to the activation of ceramide-releasing enzymes 57 , thereby suggesting the presence of a feed-forward loop in which ceramide accumulation, mitochondria impairment, and oxidative stress act synergistically to promote neuronal impairment.
To investigate the downstream effectors of the mitochondrial pathways involved in neuronal dysfunction, we evaluated changes in levels of p53, pJNK, and pP38. The selection of these proteins was driven by the fact that 1) these factors are altered in and participate to senescence-related processes; 2) their activity is intertwined with mitochondrial dysfunction; 3) their levels are modulated by ceramides 15, 48, [58] [59] [60] . L-CS was found to be effective in reducing the increased levels of p53, pJNK, and pP38 (Fig. 5) shown by the aging cultures. These results support the idea that L-CS, by reducing de novo ceramide biosynthesis, prevents the mitochondria-driven activation of senescent-related pathways.
Our findings converge towards the possibility of a beneficial effect of L-CS in aging cultures. The analysis of the data on spontaneous synaptic activity supports this hypothesis and indicates that L-CS is effective in reducing the aberrant neuronal firing of aged cultures (Fig. 4) . Thus, one can envision that the age-dependent accumulation of ceramide adducts is a critical contributor to the functional alterations in neuronal connectivity observed in either preclinical models or neurological conditions 43, 61, 62 . A robust drug-related effect was also observed in control cultures, a setting that exhibited only modest reductions of ceramide levels (Fig. 5) . This discrepancy can be, at least in part, explained by drug-related effects on the in vitro neuronal development 7 and/or by off-target effects of the compound 63 .
Conclusions
The results presented here provide experimental support for the presence of an agingrelated cascade of events that include mitochondrial dysfunction, Ca 2+ dysregulation, impaired neuronal Ca 2+ signaling, and alterations of aging-related markers in which de novo ceramide biosynthesis acts a critical intermediate. Our findings indicate that ceramide modulation is not a mere response to aging-related stimuli but may play instead an active role in shaping the senescence-related processes 13 . Indeed, they are in line with a growing body of literature supporting a key role for lipids and lipid dysmetabolism in aging and neurodegenerative conditions 12, 13, [64] [65] [66] [67] [68] [69] . In this context, ceramides are emerging as important peripheral biomarkers of age-related pathologies since changes in their plasmatic levels are now considered to be highly predictive of aging-related cognitive decline and conversion to AD 13, 70, 71 . The present study has several limitations. For instance, our near-pure neuronal system does not investigate the impact of ceramides on the senescent phenotype of non-neuronal cells (i.e., astrocytes, microglia, etc.), an important area of investigation given the key role played by ceramides in promoting the glia-mediated release of pro-inflammatory cytokines in the context of cell death 16, 52, 72 . Furthermore, due to the limitations of our experimental setting, we have not explored sex-related differences as gender has been recently shown to have a significant impact on ceramide metabolism 66 . Finally, the L-CS-driven effects occasionally observed in control cultures suggest that the compound may also act through mechanisms independent on ceramide biosynthesis, which warrant further investigation. Although the L-CS biological activity is distinct from the one modulated by D-cycloserine (an N-methyl-D-aspartate receptor co-agonist), it cannot be ruled out that a marginal isomerization of the compound accounts for some of the observed offtarget effects.
Our results raise several intriguing questions on the interplay between ceramides and other neurodegenerative markers. For instance, do ceramides act on the same targets affected by proteins and pathways involved in AD, PD, or ALS (i.e., amyloid, tau, α-synuclein, TDP-43) or do they engage independent and/or synergistic pathways? Is there a common molecular trigger for the accumulation of ceramides and misfolded proteins? Does the manipulation of the pathological accumulation of amyloid, tau, α-synuclein, or TDP-43 affect ceramide metabolism or vice versa? Testing these questions in disease-relevant preclinical and clinical settings will have a great translational value. Nevertheless, the present results indicate that the pharmacological modulation of the de novo ceramide biosynthesis may be a promising target for the treatment of age-related pathologies as shown in preclinical models of AD 20 , insulin resistance 51 , and microglia-driven inflammation 52 , conditions in which the ceramide build-up has been proposed to be involved in the disease onset and progression. Also, the L-CS off-target effects and its short half-life offer the possibility to investigate and test novel, brain penetrant, long-lasting, and more selective SPT inhibitors 16 .
Experimental procedures

Materials
Culture media and sera were purchased from GIBCO (ThermoFisher). All the fluorescent indicators employed in the study (fura-2 AM, fluo-4 AM, hydroethidine, TMRE, and MitotrackerGreen FM) were obtained from Molecular Probes (ThermoFisher). Unless otherwise specified, all commonly used chemicals were from Sigma-Aldrich.
Neuronal cortical cultures
The procedures involving animals were approved by the institutional Ethics Committee (47/2011/CEISA/COM) and performed following institutional guidelines and national and international laws and policies. Female mice were caged in groups, while male mice were singlehoused. Mice were kept on a 12:12 light/dark cycle and had free access to food and water. All efforts were made to minimize the number of animals employed and their suffering. Neuronal cortical cultures were, as previously described 41 , prepared from fetal CD1 mice at 14 days of gestation and plated onto Poly-DL-lysine (100 µg/ml) and laminin (5 µg/ml) coated Petri dishes or glass coverslips. Three days after plating, the proliferation of non-neuronal cells was halted by the addition of cytosine β-D-arabinofuranoside (5 µM). Every three days 25% of the growth medium was replaced with fresh Neurobasal. Routinely-performed functional experiments and visual inspections show that the cytostatic treatment robustly affected glia proliferation (around 5-10 % of non-neuronal cells per culture).
Ceramide quantification
Ceramides analysis was performed as previously described 73 . Briefly, 100 µL of sample, lysed with a probe sonicator, were mixed to 300 µL of chloroform:methanol 2:1 v/v with an internal standard mix containing sphinganine d17:0, sphingosine d17:1, sphingosine-1-phosphate d17:1, sphinganine-1-phosphate d17:0, sphingosine-1-phosphate d17:1, glucosylceramide (d18:1/17:0), and ceramide (d18:1/17:0). The organic phase was dried and reconstituted in 100 µL of H2O:methanol:isopropanol:acetonitrile (7:2:0.5:0.5, v/v). The LC-MS/MS system was an HPLC Alliance HT 2795 Separations Module coupled to Quattro UltimaPt ESI tandem quadrupole mass spectrometer (Waters Corporation) operating in the positive ion mode. For the chromatographic separation, Ascentis Express Fused-Core C18 2.7 µm, 7.5 cm x 2.1 mm columns were used. Elution was achieved through a gradient of mobile phases, starting from 50% to 100% of methanol:isopropanol:acetonitrile 4:1:1 v/v (solvent B), water was used as solvent A. The total run time was 25 min. The flow rate was 0.25 mL/min. The capillary voltage was 3.8 kV, source temperature was 120 °C, the de-solvation temperature was 400 °C, and the collision cell gas pressure was 3.62×10−3 mbar argon. Chromatograms were used quantify the following molecules: sphinganine (d18:0), sphingosine (d18:1), sphinganine-1-phosphate (d18:0), sphingosine-1-phosphate (d18:1), C16 ceramide (d18:1/16:0), C16 dihydroceramide (d18:0/16:0), C18 Ceramide (d18:1/18:0), C16 glucosyl(ß) ceramide (d18:1/16:0), C22 ceramide (d18:1/22:0), C24 ceramide (d18:1/24:0) and C24 dihydroceramide (d18:0/24:0).
Live-cell imaging
Live neuronal imaging experiments were performed, as previously described 74, 75 , by employing a Nikon Eclipse TE300 inverted microscope equipped with a Xenon lamp, a 40× Nikon epifluorescence oil immersion objective (N.A.: 1.3) and a 12-bit Orca CCD camera (Hamamatsu). Alternatively, experiments were performed with a Zeiss Axio Examiner.D1 upright microscope equipped with an Optoscan monochromator (Cairn), a 20x or 40x Zeiss epifluorescence water immersion objective (N.A.: 1.0), and a 16-bit Evolve 512 EMCCD camera (Photometrics). Images were acquired and stored for offline analysis with Metafluor 7.7 software (Molecular Devices).
[Ca 2+ ]i measurements
Measurements of [Ca 2+ ]i were performed by employing the ratiometric dye fura-2 or the single wavelength dye fluo-4, as previously described 74, 75 . Briefly, cortical cultures were loaded with fluo-4 AM (3 μM) or fura-2 AM (3 μM) plus 0.1% Pluronic F-127 (ThermoFisher) in a HEPES-buffered saline solution (HCSS) whose composition was: 120 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2, 20 mM HEPES, 15 mM glucose, 1.8 mM CaCl2, 10 mM NaOH, and pH 7. . 2+ ]i spikes analysis Fluo-4 AM (Ex λ: 473 ± 20 nm, Em λ: 525 ± 25 nm) was employed to measure spontaneous [Ca 2 + ]i transients. Images were acquired at full-frame resolution (512 x 512 pixels; binning 1x) at 1 Hz sampling rate for up to 5 min. Conversely, to evaluate dendritic Ca 2+ transients, the camera frame was cropped (with a 1x binning) around proximal primary dendritic branches and images acquired at a 10 Hz sampling rate for up to 60 s.
Spontaneous [Ca
Fluorescence changes of each cell/dendrite were expressed as a percentage of baseline fluorescence (% of basal fluorescence). Spontaneous [Ca 2+ ]i transients from vehicle-and L-CStreated cultures were analyzed with a custom made MATLAB code, as previously described 28 . For statistical analysis, we took into consideration only fluorescence values 50 % larger than baseline for somata and 25 % larger than baseline for dendrites. Cells that failed to display Ca 2+ transients when the threshold was set at 25% of the baseline were excluded from the analysis.
Measurements of mitochondrial Δp
Measurements of the mitochondrial Δp were performed as previously described 74 , with minor modifications. Briefly, cultured cortical neurons were loaded with 50 nM of TMRE for 30 min in culture medium at 37° C. TMRE fluorescence (Ex λ: 530 ± 15 nm, Em λ: 575-610 nm) changes of each cell (Fx) were normalized to basal fluorescence intensity (F0) obtained by exposing the cells to CCCP (10 µM). Experiments were halted when, after CCCP application, the fluorescence signal was stable for up to 30 s.
Mitochondria morphology analysis
Neurons plated on glass coverslips were washed and loaded for 30 min at room temperature with MitoTracker Green FM (100 nM in HCSS), a mitochondrially-targeted and Δp-insensitive dye. Cells were imaged on the stage of an inverted Zeiss LSM800 Super-resolution confocal microscope equipped with a 488 nm LED-based laser line, a 63x oil immersion objective (N.A.: 1.4), and an Airyscan imaging module. Appropriate emission filter-sets were selected with the built-in Smart Setup function. Laser power was maintained at the minimum (0.65%) to achieve an optimum signalto-noise ratio and avoid photobleaching. Acquisition parameters (i.e., detector and digital gain) were constant among experimental sessions. Single-plane images were acquired with the Zeiss ZEN proprietary software and stored for offline analysis.
Confocal micrographs were Airyscanned to obtain super-resolution images that were further analyzed with the ImageJ-based MiNA toolkit, following the developer workflow 26 . Briefly, images were preprocessed (applied algorithms: Unsharp Mask, CLAHE, Median Filtered), then binary transformed and skeletonized to allow parameters generation and recording.
ROS measurements
Evaluation of basal ROS production was performed by employing hydroethidine (HEt; Ex λ: 530 ± 15 nm, Em λ: 575-610 nm), a fluorescent probe sensitive to ROS. Basal ROS production levels were measured after loading vehicle-or L-CS-treated cultures with HEt (5 µM). Cells were loaded for 2 h at 37 °C to allow dye oxidation by endogenously released ROS. Resting fluorescence signals were recorded and normalized to that of vehicle-treated control cultured neurons.
Western blot analysis
Western blot analysis was performed as previously described 78, 79 . Briefly, control and treated cells were lysed in ice-cold RIPA buffer (phosphate buffer saline pH 7.4 containing 0.5% sodium deoxycholate, 1% Igepal, 0.1% SDS, 5mM EDTA, 1% protease and phosphatase inhibitor cocktails). Protein lysates (20 μg) were separated on 8-14% SDS-polyacrylamide gel and electroblotted onto a polyvinyldifluoride membrane (PVDF). Nonspecific binding sites were blocked by 5% non-fat dry milk (Bio-Rad Laboratories) in Tris buffered saline (TBS: 20mMTris-HCl, pH 7,4, containing 150mM NaCl) for 30 min at RT. Membranes were then incubated overnight at 4°C with the following primary antibodies, diluted with TBS containing 0,1% Tween 20 (TBS-T) and 5% non-fat dry milk: rabbit HRP-conjugated actin 1:10000 (Cell Signaling); rabbit p-JNK and JNK 1:200 (Santa Cruz); p-ERK1,2 1:200 (Santa Cruz); rabbit p-Akt 1:1000 (Cell Signaling); Erk1,2 1:200 (Santa Cruz); rabbit p-P38 and rabbit P38 1:1000 (Cell Signaling); rabbit P53 1:1000 (Cell Signaling); rabbit p-ERK5 and rabbit ERK5 1:1000 (Cell Signaling). As secondary antibodies, peroxidase conjugated anti-rabbit or anti mouse IgG (1:10000; Vector Laboratories) were used. Immunoreactive bands were visualized by ECL (Bio-Rad Laboratories), according to the manufacturer's instructions. The relative densities of the immunoreactive bands were determined and normalized with respect to Actin, using ImageJ software. Values were given as relative units (RU).
Data and statistical analysis
Data are represented as box plots. . No statistical methods were used to predetermine the sample size. Statistical analysis was performed by two-way ANOVA (cell culture age vs. treatment) followed by Tukey's post-hoc test. Differences in ceramide levels and dendritic Ca 2+ transients were analyzed by unpaired Student's t-test. Experimenters were not blinded to treatment allocation. By conventional criteria, P values are represented as * for P ≤ 0.05 and ** for P ≤ 0.01. . In C and E-F means were compared by unpaired Student t-test. In G means were compared by two-way ANOVA followed by Tukey post-hoc test. * indicates p<0.05, *** p<0.001. To evaluate the primary source of ROS in our system we performed pharmacological manipulations aimed at selectively observing ROS of mitochondrial and non-mitochondrial origin. HEt-loaded control cortical neurons were challenged with NMDA + glycine (50 µM + 10 µM), a maneuver that triggers a robust generation of ROS from both mitochondrial and non-mitochondrial sources 81, 82 . After 5 minutes, NMDA receptor (NMDAR) overactivation was halted by bath application of the noncompetitive NMDAR antagonist MK-801 (10 µM). In (A), traces depict NMDA-driven ROS generation in control neurons (black trace) and in cells bathed and challenged in a solution in which glucose was replaced with pyruvate (15 mM), an established paradigm aimed at promoting ROS generation only from mitochondria. No differences were observed between the two conditions. In (B), neurons were challenged with (blue trace) or without (black trace) apocynin (500 µM), an inhibitor of NADPH oxidase activity. No differences were observed between the two conditions. Collectively, these findings indicate that mitochondria are the primary source of ROS in our cortical cultures. 
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